Results
1 -
4 of
4A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma, Investigational New Drugs Chemoprevention of melanoma, Current Oncology Reports Phase I news from the 9nd Annual Meeting of the American Association for Cancer Research, Inpharma Weekly